GSK And Pfizer Join Forces In New HIV-Focused Venture
This article was originally published in The Pink Sheet Daily
Executive Summary
ViiV Healthcare will market the two companies' combined portfolio of 10 HIV drugs while also taking over a 17-compound R&D operation.